Detalles de la búsqueda
1.
Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson's disease mice.
J Neuroinflammation
; 19(1): 319, 2022 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36587195
2.
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.
Haematologica
; 106(2): 363-374, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31879324
3.
Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells.
Immunity
; 37(1): 134-46, 2012 Jul 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-22683122
4.
TLR signals license CD8 T cells to destroy oligodendrocytes expressing an antigen shared with a Listeria pathogen.
Eur J Immunol
; 49(3): 413-427, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666625
5.
Short-term cytokine stimulation reveals regulatory T cells with down-regulated Foxp3 expression in human peripheral blood.
Eur J Immunol
; 48(2): 366-379, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29023682
6.
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.
Transpl Int
; 31(4): 436-450, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29284181
7.
Interrupting CD28 costimulation before antigen rechallenge affects CD8(+) T-cell expansion and effector functions during secondary response in mice.
Eur J Immunol
; 46(7): 1644-55, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27122236
8.
In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice.
Eur J Immunol
; 46(5): 1193-202, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26711629
9.
Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.
Cancer Immunol Immunother
; 66(3): 319-332, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27896368
10.
High-density preculture of PBMCs restores defective sensitivity of circulating CD8 T cells to virus- and tumor-derived antigens.
Blood
; 126(2): 185-94, 2015 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26024876
11.
In vitro polyclonal activation of conventional T cells with a CD28 superagonist protects mice from acute graft versus host disease.
Eur J Immunol
; 45(7): 1997-2007, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25907100
12.
Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
Eur J Immunol
; 45(2): 480-91, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25382658
13.
Inducible deletion of CD28 prior to secondary nippostrongylus brasiliensis infection impairs worm expulsion and recall of protective memory CD4⺠T cell responses.
PLoS Pathog
; 10(2): e1003906, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24516382
14.
Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
Exp Dermatol
; 25(4): 293-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26661498
15.
From TGN1412 to TAB08: the return of CD28 superagonist therapy to clinical development for the treatment of rheumatoid arthritis.
Clin Exp Rheumatol
; 34(4 Suppl 98): 45-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27586803
16.
Cell contact-dependent priming and Fc interaction with CD32+ immune cells contribute to the TGN1412-triggered cytokine response.
J Immunol
; 192(5): 2091-8, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24470499
17.
Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice.
Stroke
; 46(1): 212-20, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25378432
18.
Human regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08.
Eur J Immunol
; 44(4): 1225-36, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24374661
19.
A novel multicolor immunostaining method using ethynyl deoxyuridine for analysis of in situ immunoproliferative response.
Histochem Cell Biol
; 144(3): 195-208, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25976155
20.
Cell-intrinsic and -extrinsic control of Treg-cell homeostasis and function revealed by induced CD28 deletion.
Eur J Immunol
; 43(1): 188-93, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23065717